Elevated frequency of p53 genetic mutations and AgNOR values in squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 36, Issue 2, 2009, Pages 220-228

  Bukhari, Mulazim H ^a,b   Niazi, Shahida ^a   Khaleel, Muhammad Eyyaz ^a   Sharif, M Anwar ^b   Ghani, Rubina ^c   Mehmood, Muhammad T ^d   Tahseen, Muhammad ^d   Chaudhry, Naseer A ^a   Hasan, Mumtaz ^b  

^a Department of Pathology ^*

^b KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^c BAQAI MEDICAL UNIVERSITY   (Pakistan)

^d SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER GRADING; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN CARCINOMA; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL PAPILLOMA;

ANTIGENS, NUCLEAR; FEMALE; HUMANS; MALE; MUTATION; NEOPLASMS, BASAL CELL; PAKISTAN; PAPILLOMA; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58649084382     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01006.x     Document Type: Article

References (52)

1. Murad A., Ratner D. Primary care: cutaneous squamous-cell carcinoma. N Engl J Med 2001 344 : 975.
2. Albert MR, Weinstock MA. Keratinocyte carcinoma. CA Cancer J Clin 2003 53 : 292.
3. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991 4 : 196.
4. Abbey LM, Page DG, Sawyer DR. The clinical and histopathologic features of a series of 464 oral squamous cell papillomas. Oral Surg Oral Med Oral Pathol 1980 49 : 419
5. Soehnge H, Ouhtit A, Ananthaswamy HN. Mechanisms of induction of skin cancer by UV Radiation. Frontiers in Biosci 1997 2 : 538.
6. Nogita T, Kamikawa T, Kawashima M. Significance of preexistent conditions in basal cell carcinoma on the lower extremities. Int J Dermatol 1993 32 : 350.
7. Kirkham N. Tumors and cysts of the epidermis. In Elder D, ed. Lever's histopathology of the skin, 8th ed. Philadelphia : Lippincott-Raven 1997 : 719.
8. Poljak M, Cerar A, Orlowska J. p53 protein expression in esophageal squamous cell papillomas: a study of 36 lesions. Scand J Gastroenerol 1996 1 : 10.
9. Cabral ES, Auerbach A, Kiilian KJ, Barrett TL, Cassarino DS. Distinction of benign sebaceous proliferations from sebaceous carcinomas by lmmunohistochemistry. Am J Dermatopath. 2006 28 : 465 71.
10. Hussein MR. Skin cancer in Egypt: a word in your ear. Cancer Biol Ther 2005 4 : 593.
11. Bukhari MH, Bajwa R, Khan SA, Chaudhry NA. Tayyab M. Vitamin 'A' deficiency enhances the effect of 7-12 Dimethyl-Benz-a-Anthracene (DMBA) induced skin carcinogenesis. J Coll Physicians Surg Pak 1998 8 : 101.
12. Bukhari MH, Salaria SM, Niaz Z, et al. Mutation of p53 in skin papilloma and tubular breast adenoma of albino mice. J Coll Physician Surge Pak 2006 16 : 280.
13. Bukhari MH, Qureshi SS, Niazi S, et al. Chemotherapeutic role of retinoids in chemically induced skin carcinogenesis on albino mice. Int J Dermatol 2007 46 : 1160.
14. 2) of Madina Munawra on chemically induced carcinogenesis in albino mice by protecting mutation of p53. Ann King Edward Med Coll 2004 10 : 236.
15. Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 2003 9 : 228 34.
16. Owens DM. p53, chemokines, and squamous cell carcinoma. J Clin Invest 2007 117 : 1752.
17. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000 408 : 307.
18. Guimaraes DP, Hainaut P. TP53: a key gene in human cancer. Biochimie 2002 84 : 83.
19. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol 2003 39 : 222.
20. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003 116 : 4077.
21. Giono LE, Manfredi JJ. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 2006 209 : 13.
22. Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000 12 : 229.
23. Bradford CR. Predictive factors in head and neck cancer. Hematol Oncol Clin North Am 1999 13 : 777.
24. Hussein MR. Alterations of p53 and Bcl-2 protein expression in the laryngeal intraepithelial neoplasia. Cancer Biol Ther 2005 4 : 213.
25. Hirsch SM, DuCanto J, Caldarelli DD, Hutchinson JC, Coon JS. Nucleolar organiser regions in squamous cell carcinoma of the head and neck. Laryngoscope 1992 102 : 39.
26. Xin Xie, Clausen OPF, Sudbo J, Boysen M. Diagnostic and prognostic value of nucleolar organiser regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer 1997 79 : 2200.
27. Jones AS, Roland NJ, Caslin AW, Cooke TG, Cooke LD, Foster G. A comparison of cellular proliferation markers in squamous cell carcinoma of head and neck. J Laryngol Otol 1994 108 : 859.
28. Kobayashi I, Matsuo K, Ozeki S, Ohishi M, Ishibashi Y, Sakai H. The proliferate activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining. Hum Pathol. 1995 26 : 907 13.
29. Bukhari MH, Niazi S, Khan SA, et al. Modified method of AgNOR staining for tissue and interpretation in histopathology. Int J Exp Pathol 2007 88 : 47.
30. Bukhari MH, Niazi S, Hashmi IU, et al. Use of AgNOR index in grading and differential diagnosis of astrocytic lesions of brain. Pak J Med Sci 2007 23 : 206.
31. Khaled A, Imamura Y, Noriki S, Fukuda M. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability. Eur J Histochem 2000 44 : 143.
32. Romao-Correa RF, Maria DA, Soma M. Nucleolar organizer region staining patterns in paraffin-embedded tissue cells from human skin cancers. J Cutan Pathol 2005 32 : 323.
33. Lawrence WD, Abdul-Karim FW, Crum C, Fu YS. Recommendations for the reporting of surgical specimens containing uterinecervical neoplasms. Mod Pathol 2000 13 : 1029.
34. Qin LX, Tang ZY, Ma ZC, et al. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol 2002 8 : 459.
35. Gentra System. Pure Gene DNA purification system. Genomic DNA purification kit, instruction. Minnesota : Gentra System, 2006.
36. Shi SR, Cote RJ, Wu L, et al. CR.DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 2002 50 : 1005.
37. Rodgers JL, Nicewander WA. 'Thirteen ways to look at the correlation coefficient'. Am Stat 1988 42 : 59.
38. 2 from contingency tables, and the calculation of P'. J R Stat Soc 1922 85 : 87.
39. Friesland S, Mellin H, Munck-Wikland E, et al. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - relation to radiotherapy response and survival. Anticancer Res 2001 21 : 529.
40. Yie Fang S, Yan JJ, Ohyama M. Assessment of p53 protein expression in normal mucosa and benign and malignant lesions of the nasal cavity. Oncology 1998 55 : 168.
41. Reszec J, Sulkowska M, Koda LK, et al. Evaluation of apoptosis markers in conjunctival and eyelid benign and malignant tumors. Ann N Y Acad Sci 2003 1010 : 748.
42. Maria A, Copete MA, Wendt K, Chen SY. Expression of p53, Ki-67 and cytokeratin-4 (CK4) in oral papillomas. J Oral Pathol Med 1997 26 : 211.
43. O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk M. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses. Diagn Mol Pathol 2001 10 : 190.
44. Cabrini R, Schwint A, Mendez A, Femopase F, Lanfranchi H, Itoiz ME. Morphometric study of nucleolar organizer regions in human oral normal mucosa papilloma and squamous cell carcinoma. J Oral Pathol Med 1992 21 : 275.
45. Kim KH, Park EJ, Seo YJ, et al. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol 2006 33 : 319.
46. Rajabi MA, Rajabi P, Moghaddam NA. Carcinoma tissues and adjacent nontumoral epidermis from sun-exposed areas of the head and neck. Arch Irani Med 2006 9 : 46.
47. Hanae O, Shin-ichi N, Tamotsu S. Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms. Am J Dermatopathol 1996 18 : 580.
48. Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res 2005 571 : 65.
49. Maurer TA, Christian KV, Kerschmann RL, et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 1997 133 : 577.
50. Masuya D, Huang C, Liu D, et al. The HAUSP gene plays an important role in non-small cell lungs carcinogenesis through p53 dependent pathways. J Pathol 2006 208 : 724.
51. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cefl carcinoma. Proc Natl Acad Sci U S A 1991 Nov 15 88 : 10124.
52. Poeta ML, Manola J, Goldwasser MG, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. JEMJ 2007 357 : 2552.